Advanced Search

Study Preview



Study Title and Description

Treatment of postmenopausal women with osteoporosis or low bone density with raloxifene. Raloxifene Study Group.



Key Questions Addressed
3 Key Question 3. What are the harms of using medications to reduce risk for primary breast cancer? Key Question 3a. Do harms of risk-reducing medications vary by timing of initiation and/or duration of use? Key Question 3b. Do harms of risk-reducing medications persist beyond discontinuation of use?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Treatment of postmenopausal women with osteoporosis or low bone density with raloxifene. Raloxifene Study Group.
Author Meunier PJ., Vignot E., Garnero P., Confavreux E., Paris E., Liu-Leage S., Sarkar S., Liu T., Wong M., Draper MW.
Country Service de Rhumatologie et de Pathologie Osseuse, Hôpital Edouard Herriot, Lyon, France.
Year 1999
Numbers Pubmed ID: 10692984

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Key Questions 1-4


Results & Comparisons

No Results found.